Figure 5. Systematic administration of MicroRNA-153 suppresses HCC development in C57BL/6 mice.
(A–B) Number of HCC tumors/liver (A) and tumor size (mm3) (B) in NC-, and miR-153 antigomir-treated mice. (C–D) Representative protein levels of WWOX, Cyclin D1 and p21 were determined in the two groups of tumors.